scholarly journals Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double‐blind, parallel‐controlled, phase 1 study

2021 ◽  
Vol 9 (2) ◽  
Author(s):  
Hong Zhang ◽  
Min Wu ◽  
Jixuan Sun ◽  
Xiaoxue Zhu ◽  
Cuiyun Li ◽  
...  
2011 ◽  
Vol 59 (09) ◽  
pp. 440-444
Author(s):  
Feng-Guo Xu ◽  
Ying Liu ◽  
Zun-Jian Zhang ◽  
Yuan Tian ◽  
Yun Chen

2021 ◽  
Author(s):  
Nadine C. Salisch ◽  
Kathryn E. Stephenson ◽  
Kristi Williams ◽  
Freek Cox ◽  
Leslie van der Fits ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document